n-(2'-(dimethylamino)ethyl)acridine-4-carboxamide has been researched along with Leukemia L 1210 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Atwell, GJ; Baguley, BC; Bos, CD; Denny, WA | 1 |
| Baguley, BC; Ching, LM; Darkin, SJ; Lawson, PA; Ralph, RK; Schneider, E | 1 |
2 other study(ies) available for n-(2'-(dimethylamino)ethyl)acridine-4-carboxamide and Leukemia L 1210
| Article | Year |
|---|---|
Potential antitumor agents. 56. "Minimal" DNA-intercalating ligands as antitumor drugs: phenylquinoline-8-carboxamides.
Topics: Animals; Antineoplastic Agents; Chemical Phenomena; Chemistry; DNA; Intercalating Agents; Leukemia L1210; Leukemia P388; Ligands; Lung Neoplasms; Quinolines; Structure-Activity Relationship; Tumor Cells, Cultured | 1988 |
Cell line selectivity and DNA breakage properties of the antitumour agent N-[2-(dimethylamino)ethyl]acridine-4-carboxamide: role of DNA topoisomerase II.
Topics: Acridines; Aminacrine; Aminoacridines; Amsacrine; Animals; Antineoplastic Agents; Cell Survival; DNA Damage; DNA Topoisomerases, Type II; Dose-Response Relationship, Drug; Leukemia L1210; Leukemia P388; Leukemia, Experimental; Mice; Neoplasm Proteins; Quinacrine; Tumor Cells, Cultured; Tumor Stem Cell Assay | 1988 |